


Ask a doctor about a prescription for DULOXETINE CINFAMED 60 mg HARD GASTRO-RESISTANT CAPSULES
Package Leaflet: Information for the User
Duloxetine Cinfamed 60 mg Hard Gastro-Resistant Capsules EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information
This medicine contains the active substance duloxetine. Duloxetine Cinfamed increases the levels of serotonin and noradrenaline in the nervous system.
Duloxetine is used in adults to treat:
Duloxetine starts to work in most people with depression or anxiety within 2 weeks of starting treatment, but it may take between 2 and 4 weeks before you start to feel better. Tell your doctor if you do not notice any improvement after this time. Your doctor may continue to give you this medicine when you are feeling better to prevent your depression or anxiety from returning.
In people with diabetic neuropathic pain, it may take a few weeks before you start to feel better. Consult your doctor if you do not feel better after 2 months.
Do not take Duloxetine Cinfamed if:
Consult your doctor if you have high blood pressure or heart disease. Your doctor will tell you if you should take duloxetine.
Warnings and precautions
Duloxetine may not be suitable for you due to the following reasons. Consult your doctor before starting to take duloxetine if:
Duloxetine may cause a feeling of restlessness or inability to sit or stand still. If this happens, you should tell your doctor.
Some medicines in the same class as duloxetine (called SSRIs/SNRIs) may cause symptoms of sexual dysfunction (see section 4). In some cases, these symptoms persist after stopping treatment.
Suicidal thoughts and worsening of your depression or anxiety disorder
If you are depressed and/or have anxiety disorders, you may sometimes have thoughts of self-harm or suicide. These thoughts may be increased at the start of treatment with antidepressants, as all these medicines take time to work, usually about two weeks but sometimes longer.
It is more likely that you will have these thoughts if:
Contact your doctor or go to the hospital immediately if you have any thoughts of self-harm or suicide.
It may be helpful for you to tell a relative or close friend that you are depressed or have an anxiety disorder, and ask them to read this leaflet. You can ask them to tell you if they notice that your depression or anxiety is getting worse, or if they are worried about changes in your behavior.
You should also contact your doctor:
If you experience signs and symptoms of agitation, hallucinations, loss of coordination, rapid heartbeat, increased body temperature, rapid changes in blood pressure, overactive reflexes, diarrhea, coma, nausea, vomiting, as you may be suffering from serotonin syndrome.
In its most severe form, serotonin syndrome can resemble Neuroleptic Malignant Syndrome (NMS). The signs and symptoms of NMS can include a combination of fever, rapid heartbeat, sweating, severe muscle stiffness, confusion, increased muscle enzymes (determined by a blood test).
Children and adolescents under 18 years
Duloxetine should not normally be used in children and adolescents under 18 years. Also, you should know that patients under 18 years who take this type of medicine have an increased risk of side effects such as suicidal attempts, suicidal thoughts, and hostility (mainly aggression, oppositional behavior, and anger). Despite this, your doctor may prescribe this medicine to patients under 18 years if they decide that it can be beneficial for the patient. If your doctor has prescribed duloxetine to a patient under 18 years and you want to discuss it, please go back to the doctor. You should inform your doctor if any of the above symptoms appear or worsen in patients under 18 years who are taking duloxetine. Additionally, in this age group, the long-term safety effects of duloxetine related to growth, maturation, and cognitive and behavioral development have not yet been demonstrated.
Other medicines and Duloxetine Cinfamed
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
The main component of this medicine, duloxetine, is used in other medicines for other treatments:
It should be avoided to use more than one of these medicines at the same time. Check with your doctor if you are already using other medicines that contain duloxetine.
Your doctor will decide if you can take duloxetine with other medicines. Do not start or stop taking any medicine, including those obtained without a prescription and herbal remedies, without first talking to your doctor.
You should also tell your doctor if you are taking any of the following medicines:
Monoamine oxidase inhibitors (MAOIs):you should not take duloxetine if you are taking, or have taken in the last 14 days, another antidepressant medicine called a monoamine oxidase inhibitor (MAOI). Examples of MAOIs include moclobemide (an antidepressant) and linezolid (an antibiotic). Taking an MAOI with many prescription medicines, including this medicine, can cause serious side effects, even life-threatening. You should wait at least 14 days after stopping treatment with an MAOI before taking duloxetine. Similarly, you should wait at least 5 days after stopping treatment with duloxetine before starting treatment with an MAOI.
Medicines that cause drowsiness:These include medicines prescribed by your doctor such as benzodiazepines, strong painkillers, antipsychotics, phenobarbital, and antihistamines.
Medicines that increase serotonin levels:Triptans, tramadol, tryptophan, selective serotonin reuptake inhibitors (SSRIs, such as paroxetine and fluoxetine), serotonin-norepinephrine reuptake inhibitors (SNRIs, such as venlafaxine), tricyclic antidepressants (such as clomipramine, amitriptyline), pethidine, St. John's Wort, and MAOIs (such as moclobemide and linezolid). These medicines increase the risk of side effects; if you notice any unusual symptoms when using any of these medicines with duloxetine, you should tell your doctor.
Oral anticoagulants or antiplatelet agents:Medicines that thin the blood or prevent blood clots. These medicines may increase the risk of bleeding.
Taking Duloxetine Cinfamed with food, drinks, and alcohol
This medicine can be taken with or without food. You should be careful if you drink alcohol while being treated with duloxetine.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and using machines
During treatment with duloxetine, you may feel drowsy or dizzy. Do not drive or use tools or machines until you know how the treatment with duloxetine affects you.
Duloxetine Cinfamed contains sucrose
This medicine contains sucrose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Duloxetine Cinfamed contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per capsule; this is essentially "sodium-free".
Follow exactly the instructions of administration of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Duloxetine should be taken by mouth. You should swallow the capsule whole with water.
For depression and diabetic neuropathic pain:
The recommended dose of duloxetine is 60 mg once a day, but your doctor will prescribe the dose that is best for you.
For generalized anxiety disorder:
The usual starting dose of duloxetine is 30 mg once a day, after which most patients will receive 60 mg once a day, but your doctor will prescribe the dose that is best for you. The dose may be adjusted up to 120 mg per day depending on your response to duloxetine.
To help you remember to take this medicine, it may be useful to take it at the same time every day.
Discuss with your doctor how long you should take duloxetine. Do not stop taking this medicine or change your dose without consulting your doctor. It is important to treat your condition properly to help you improve. If you do not treat it, your condition may not disappear and may become more severe and more difficult to treat.
If you take more Duloxetine Cinfamed than you should
Call your doctor or pharmacist immediately if you take more duloxetine than prescribed by your doctor. Symptoms produced by an overdose include drowsiness, coma, serotonin syndrome (a rare reaction that can cause intense happiness, drowsiness, clumsiness, restlessness, feeling drunk, fever, sweating, or muscle stiffness), seizures, vomiting, and rapid heartbeat.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Duloxetine Cinfamed
If you forget to take a dose, take it as soon as you remember. However, if it is time for your next dose, skip the missed dose and take a single dose as you normally would. Do not take a double dose to make up for missed doses. Do not take more duloxetine than prescribed for you in a day.
If you stop taking Duloxetine Cinfamed
DO NOT stop taking your capsules without your doctor's advice, even if you feel better.If your doctor thinks you do not need to continue taking duloxetine, they will tell you to reduce your dose over at least 2 weeks before stopping treatment.
Some patients who have stopped taking this medicine suddenly have experienced symptoms such as:
These symptoms are usually not serious and disappear within a few days, but if you have symptoms that are bothersome, ask your doctor for advice.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them. These effects are usually mild to moderate and disappear, often, within a few weeks.
Very Common Adverse Effects (may affect more than 1 in 10 patients)
Common Adverse Effects (may affect up to 1 in 10 patients)
Children and adolescents under 18 years of age with depression treated with this medicine suffered a decrease in weight when they started taking this medicine. After 6 months of treatment, weight increased to similar levels as other children and adolescents of the same age and sex.
Uncommon Adverse Effects (may affect up to 1 in 100 patients)
Rare Adverse Effects (may affect up to 1 in 1,000 patients)
Very Rare Adverse Effects (may affect up to 1 in 10,000 patients)
Adverse Effects with Unknown Frequency (cannot be estimated from the available data)
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Do not store at a temperature above 30°C.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines that you no longer need at the SIGRE point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines that you no longer need. This way, you will help protect the environment.
Composition of Duloxetine Cinfamed
The active ingredient is duloxetine.
Each capsule contains 60 mg of duloxetine (as hydrochloride).
The other components are:
Capsule content: hypromellose, talc, titanium dioxide (E-171), methacrylic acid-ethyl acrylate copolymer (1:1) dispersion at 30% (sodium lauryl sulfate, polysorbate 80, and methacrylic acid-ethyl acrylate copolymer), triethyl citrate, sugar spheres (sucrose and cornstarch), and sucrose.
Capsule shell: carmine/azure FD&C 2 (E-132), titanium dioxide (E-171), and gelatin.
Capsule body: carmine/azure FD&C 2 (E-132), yellow iron oxide (E-172), titanium dioxide (E-171), and gelatin.
Black ink: shellac, potassium hydroxide, and black iron oxide (E-172).
Product Appearance and Package Contents
Hard gelatin capsules, with a green opaque body and a blue opaque cap, filled with white to beige/salmon-colored spheres and printed with “E” on the cap and “129” on the body.
Duloxetine Cinfamed 60 mg is available in PVC/PVDC-Alu blister packs of 28 and 56 hard gastro-resistant capsules.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
Laboratorios Cinfa, S.A.
Carretera Olaz-Chipi, 10. Polígono Industrial Areta
31620 Huarte (Navarra) – Spain
Manufacturer:
TOWA PHARMACEUTICAL EUROPE, SL
C/ de Sant Martí 75-97, Martorelles
08107 Barcelona
or
Laboratorios Cinfa, S.A.
Carretera Olaz-Chipi, 10. Polígono Industrial Areta
31620 Huarte (Navarra) – Spain
Date of the Last Revision of this Prospectus:August 2024
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
You can access detailed and updated information about this medicine by scanning the QR code included in the prospectus and packaging with your mobile phone (smartphone). You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/86282/P_86282.html
QR code to: https://cima.aemps.es/cima/dochtml/p/86282/P_86282.html
The average price of DULOXETINE CINFAMED 60 mg HARD GASTRO-RESISTANT CAPSULES in November, 2025 is around 26.73 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for DULOXETINE CINFAMED 60 mg HARD GASTRO-RESISTANT CAPSULES – subject to medical assessment and local rules.